The Foundation for the Advancement of Regenerative Medicine announced on the 21st that it will hold the '2024 Advanced Regenerative Medicine Strategy Forum' at the International Conference Hall of the Korea Chamber of Commerce and Industry in Seoul on the 28th.


[Photo by Jaesaeng Medical Advancement Foundation]

[Photo by Jaesaeng Medical Advancement Foundation]

View original image

With around 300 experts in the field of advanced regenerative medicine, stakeholders, government officials, and related organizations from both domestic and international sectors expected to participate, this forum will be held as a detailed program of the '2024 RMAF Annual Symposium,' an integrated event on advanced regenerative medicine taking place from the 28th to the 29th. A total of three sessions will be conducted under the theme of "Global Technological Innovation and Data Management in Advanced Regenerative Medicine."


Session 1, related to technology and industry, will feature presentations on cell therapy technologies and clinical trends targeting solid tumors from Professor Choi Jae-hyuk of Northwestern University Feinberg School of Medicine, Professor Jung Jae-ho of Yonsei University College of Medicine, and Professor Chi Chang-song of Peking University Health Science Center. Following this, Session 2, focusing on regulation and policy, will cover "Implementation and Data Management of Advanced Regenerative Medicine in Korea, Japan, and Taiwan." In Korea, Lee Kwang-soo, Director of the Regenerative Medicine Safety Management Division at the National Institute of Health, will present; from Japan, Sato Yoji, Head of the Regenerative and Cellular Medicine Products Department at the National Institute of Health Sciences (NIHS); and from Taiwan, Carol Cheng, Secretary-General of the Taiwan Research-based Pharmaceutical Manufacturers Association (TRPMA), will deliver presentations. Finally, in Session 3, chaired by Park So-ra, President of the Foundation for the Advancement of Regenerative Medicine, the presenters from Session 2 will discuss "Enhancing Patient Accessibility and Data Management Strategies in Advanced Regenerative Medicine."



President Park So-ra stated, "Through this forum, we hope to share the latest trends in advanced regenerative medicine technologies and clinical applications among major countries, discuss the current status of patient applications, and create a global exchange platform to discuss the future direction of advanced regenerative medicine." Participation in the forum is free and available on a first-come, first-served basis through pre-registration on the website.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing